0913693 B.C. Ltd. Stock Price, News & Analysis
Company Description
0913693 B.C. Ltd. (OTC Link: REPCF) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $7.4K.
REPCF stock has gained 0.0% over the past year. Shares last traded at $0.0001.
This page provides a comprehensive overview of REPCF stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
0913693 B.C. Ltd. (REPCF) stock last traded at $0.0001. At a market capitalization of $7.4K, REPCF is classified as a micro-cap stock with approximately 73.6M shares outstanding.
Latest News
0913693 B.C. Ltd. has 10 recent news articles. Of the recent coverage, 2 articles coincided with positive price movement and 6 with negative movement. View all REPCF news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in 0913693 B.C. Ltd. (REPCF) currently stands at 250 shares, representing 0.0% of the float. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for 0913693 B.C. Ltd. (REPCF) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The days to cover has decreased 99.9% over the past year, suggesting improved liquidity for short covering. The ratio has shown significant volatility over the period, ranging from 1.0 to 1000.0 days.
REPCF Company Profile & Sector Positioning
0913693 B.C. Ltd. (REPCF) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing REPCF often look at related companies in the same sector, including Statera Biopharma Inc (STAB), Renovacare (RCAR), Novaccess Global Inc (XSNX), Comera Life (CMRA), and Evelo Biosciences (EVLO). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate REPCF's relative position within its industry.